Question 1

Who owns RARE?

Accepted Answer

ULTRAGENYX PHARMACEUTICAL IN (RARE) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Question 2

Are institutions buying or selling RARE?

Accepted Answer

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for ULTRAGENYX PHARMACEUTICAL IN, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

Question 3

What is the Smart Money Verdict on RARE?

Accepted Answer

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for ULTRAGENYX PHARMACEUTICAL IN.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
VANGUARD GROUP INC	Increased	10.3M(+1.3%)	$236.1M	0.0%	-56.32%	31
BlackRock, Inc.	Increased	6.6M(+3.2%)	$152.5M	0.0%	-43.33%	31
STATE STREET CORP	Increased	4.3M(+16.5%)	$99M	0.0%	-41.01%	35
JPMORGAN CHASE & CO	Decreased	4M(-0.9%)	$91.4M	0.0%	-34.47%	0
SANDS CAPITAL MANAGEMENT, LLC	Decreased	3.5M(-7.5%)	$80.2M	0.2%	-48.50%	0
Showing 5 of 146 results.141 more with Pro.PROUpgrade to see all →

ULTRAGENYX PHARMACEUTICAL IN

Continue exploring